RESOLUTE International : Prospective, multi-center, observational registry to evaluate the safety and clinical performance of the Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in a real-world patient population requiring stent implantation by assessing the rates of cardiac death and MI. - Resolute International.

Trial Profile

RESOLUTE International : Prospective, multi-center, observational registry to evaluate the safety and clinical performance of the Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in a real-world patient population requiring stent implantation by assessing the rates of cardiac death and MI. - Resolute International.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Zotarolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Registrational; Therapeutic Use
  • Acronyms R-Int; RESOLUTE-Int; RESOLUTE-International
  • Most Recent Events

    • 13 Dec 2012 New source identified and integrated (Clinical Trials Registry - India - CTRI2009-091-000416).
    • 05 Dec 2011 Company added as trial sponsor as reported by ClinicalTrials.gov.
    • 05 Dec 2011 Planned End Date changed from 1 Apr 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top